ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 179 filers reported holding ANI PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $17,362,000 | -13.8% | 426,162 | +30.4% | 2.40% | -18.8% |
| Q4 2019 | $20,152,000 | -45.8% | 326,778 | -35.9% | 2.95% | -34.5% |
| Q3 2019 | $37,165,000 | -17.7% | 509,952 | -7.2% | 4.50% | -11.8% |
| Q2 2019 | $45,161,000 | +16.5% | 549,401 | 0.0% | 5.11% | -1.5% |
| Q1 2019 | $38,755,000 | +56.7% | 549,401 | 0.0% | 5.18% | +57.3% |
| Q4 2018 | $24,734,000 | -14.6% | 549,401 | +7.2% | 3.29% | +80.5% |
| Q3 2018 | $28,971,000 | +9.3% | 512,401 | +29.1% | 1.82% | +6.9% |
| Q2 2018 | $26,514,000 | +21.0% | 396,923 | +5.5% | 1.71% | +19.5% |
| Q1 2018 | $21,909,000 | -9.7% | 376,314 | 0.0% | 1.43% | -56.4% |
| Q4 2017 | $24,253,000 | +22.8% | 376,314 | 0.0% | 3.27% | -3.3% |
| Q3 2017 | $19,753,000 | +50.8% | 376,314 | +34.5% | 3.38% | +26.7% |
| Q2 2017 | $13,098,000 | +353.2% | 279,866 | +379.4% | 2.67% | +304.1% |
| Q1 2017 | $2,890,000 | – | 58,375 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |